Celldex Therapeutics buy Stifel Nicolaus
Start price
18.06.24
/
50%
€33.20
Target price
18.06.25
€54.03
Performance (%)
-7.83%
Price
30.09.24
€29.60
Summary
This prediction is currently active. With a performance of -7.83%, the BUY prediction by Stifel_Nicolaus is trending in the wrong direction. This prediction currently runs until 18.06.25. The prediction end date can be changed by Stifel_Nicolaus at any time. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Celldex Therapeutics | -21.081% | -21.081% |
iShares Core DAX® | 2.685% | 2.476% |
iShares Nasdaq 100 | 0.803% | 1.741% |
iShares Nikkei 225® | -0.583% | -1.037% |
iShares S&P 500 | 0.638% | 1.486% |
Comments by Stifel_Nicolaus for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics, Inc. (NASDAQ: CLDX) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $58.00 price target on the stock.
Ratings data for CLDX provided by MarketBeat